We believe that the use of Glucagon for the arousal of patients from insulin coma and as a facilitating agent in the induction of insulin coma constitutes an important development in the modern treatment of schizophrenic psychoses, since it seems to render Sakel's treatment much easier to administer and contributes to its safety and economy.
Abstract Teaser